Excel Industries Ltd
Excel Industries is engaged in manufacturing and selling of Chemicals, Pharma intermediates and Environmental products. [1]
- Market Cap ₹ 1,167 Cr.
- Current Price ₹ 928
- High / Low ₹ 1,018 / 699
- Stock P/E 93.3
- Book Value ₹ 1,105
- Dividend Yield 1.21 %
- ROCE 9.13 %
- ROE 6.71 %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.84 times its book value
- Company has been maintaining a healthy dividend payout of 18.4%
- Debtor days have improved from 66.1 to 52.4 days.
Cons
- Company has a low return on equity of 10.5% over last 3 years.
- Earnings include an other income of Rs.30.7 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
316 | 384 | 416 | 482 | 448 | 462 | 599 | 825 | 702 | 749 | 1,178 | 1,090 | 819 | |
297 | 344 | 376 | 409 | 385 | 419 | 474 | 574 | 571 | 628 | 946 | 961 | 796 | |
Operating Profit | 18 | 40 | 40 | 72 | 63 | 44 | 125 | 250 | 131 | 122 | 232 | 129 | 22 |
OPM % | 6% | 10% | 10% | 15% | 14% | 9% | 21% | 30% | 19% | 16% | 20% | 12% | 3% |
20 | 4 | 5 | 7 | 3 | 9 | 4 | 5 | 10 | 9 | 15 | 12 | 31 | |
Interest | 9 | 12 | 12 | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 2 |
Depreciation | 10 | 10 | 11 | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 32 |
Profit before tax | 19 | 22 | 21 | 51 | 38 | 27 | 107 | 234 | 115 | 101 | 213 | 106 | 19 |
Tax % | 20% | 32% | 15% | 19% | 31% | 26% | 31% | 34% | 16% | 29% | 24% | 24% | |
15 | 15 | 18 | 41 | 26 | 20 | 74 | 153 | 96 | 71 | 161 | 80 | 13 | |
EPS in Rs | 14.09 | 13.69 | 16.50 | 34.59 | 20.18 | 15.93 | 58.78 | 122.07 | 76.42 | 56.55 | 128.23 | 63.59 | 9.95 |
Dividend Payout % | 14% | 22% | 23% | 20% | 22% | 38% | 21% | 15% | 13% | 20% | 18% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 13% |
3 Years: | 16% |
TTM: | -33% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 2% |
3 Years: | -6% |
TTM: | -90% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | -3% |
3 Years: | 5% |
1 Year: | 6% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 13% |
3 Years: | 10% |
Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 119 | 130 | 143 | 179 | 204 | 404 | 526 | 693 | 695 | 845 | 1,143 | 1,235 | 1,383 |
75 | 73 | 102 | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | |
86 | 95 | 100 | 108 | 121 | 141 | 186 | 209 | 212 | 251 | 330 | 248 | 289 | |
Total Liabilities | 286 | 303 | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,680 |
108 | 121 | 128 | 158 | 164 | 183 | 203 | 238 | 376 | 389 | 427 | 428 | 413 | |
CWIP | 6 | 5 | 20 | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 27 |
Investments | 18 | 22 | 22 | 23 | 27 | 211 | 282 | 394 | 264 | 365 | 547 | 625 | 947 |
155 | 156 | 181 | 204 | 227 | 216 | 220 | 272 | 287 | 340 | 492 | 421 | 293 | |
Total Assets | 286 | 303 | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,680 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 27 | 13 | 44 | 46 | 31 | 119 | 135 | 110 | 91 | 109 | 125 | |
-15 | -25 | -32 | -27 | -27 | 16 | -45 | -111 | -61 | -53 | -104 | -118 | |
4 | -4 | 20 | -23 | -17 | -48 | -73 | -24 | -31 | -17 | -17 | -35 | |
Net Cash Flow | 4 | -2 | 1 | -6 | 1 | -1 | 1 | -0 | 17 | 21 | -12 | -27 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 97 | 84 | 89 | 80 | 103 | 95 | 76 | 70 | 78 | 84 | 62 | 52 |
Inventory Days | 103 | 77 | 74 | 103 | 99 | 86 | 79 | 75 | 90 | 71 | 103 | 78 |
Days Payable | 98 | 91 | 81 | 84 | 112 | 98 | 123 | 108 | 122 | 126 | 112 | 64 |
Cash Conversion Cycle | 102 | 71 | 82 | 99 | 90 | 83 | 32 | 36 | 46 | 29 | 52 | 67 |
Working Capital Days | 75 | 65 | 77 | 74 | 82 | 82 | 54 | 60 | 61 | 54 | 62 | 61 |
ROCE % | 12% | 17% | 15% | 24% | 18% | 10% | 22% | 38% | 17% | 13% | 21% | 9% |
Documents
Announcements
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 18 Apr
- Closure of Trading Window 16 Apr
- Board Meeting Intimation for Notice Of Board Meeting To Be Held On 24Th May, 2024. 16 Apr
- Disclosure Under Regulation 30 Of SEBI (LODR) 5 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Products
Agrochemical intermediates: Used as intermediates in the manufacturing of various insecticides and herbicides.
Speciality Chemicals: Specialty and performance chemicals such as Phosphonates, Biocides, and Mining chemicals.
Polymer Inputs: These are used as cross-linking or branching agents for polymers like Polycarbonates, Epoxy, Polyesters, and similar systems.
Pharma APIs: APIs used in antidiabetic and anti-gout therapeutic applications. It also manufactures veterinary APIs which are used as animal feed supplements. [1] [2]